Publications by authors named "S Asin"

Introduction: Comorbidities such as hypertension, diabetes mellitus, asthma, and cardiovascular conditions have been reported to worsen the clinical progression of coronavirus disease 2019 (COVID-19) and related hospitalizations. Furthermore, the COVID-19 pandemic has disproportionately affected the historically marginalized groups, i.e.

View Article and Find Full Text PDF

Introduction: Basic military trainee (BMT) gas mask training poses a potential mechanism of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) transmission. After training, gas masks are decontaminated. Insufficient decontamination can lead to viral transmission in the next training class.

View Article and Find Full Text PDF
Article Synopsis
  • The study examines the effectiveness of two next-generation detection systems, Cepheid GeneXpert IV and BioFire FilmArray 2.0, in detecting SARS-CoV-2 during the COVID-19 pandemic amidst shortages of testing materials.
  • Researchers collected 1,080 specimens using different types of biosamples, including nasopharyngeal (NP) swabs, saliva, and oropharyngeal (OP) swabs, to compare the sensitivity and specificity of each system.
  • Findings revealed that the Cepheid platform was generally more sensitive than BioFire for certain biospecimens, while both platforms showed no significant differences when comparing NP swabs in saline versus viral transport media.
View Article and Find Full Text PDF

We evaluated the sensitivity and specificity of the Biomeme Franklin™ three9 Real-Time PCR Thermocycler and Biomeme SARS-CoV-2 Go-Strips in the detection of SARS-CoV-2. The Biomeme Franklin™ three9 platform is a portable, battery-operated system that could be used in remote settings. We assessed performance of the Biomeme SARS-CoV-2 detection system at a wide range of viral concentrations, examined cross-reactivity of the SARS-CoV-2 Go-Strips against several near-neighbor respiratory pathogens, and evaluated agreement against the BioFire® Respiratory Panel 2.

View Article and Find Full Text PDF

In addition to the prices they negotiate with private health insurers, most providers also have a cash price schedule for patients who have the wherewithal to ask and are willing to pay in full when they receive a service. This is the first study that estimates the potential cost saving of allowing privately-insured consumers to observe both in-network negotiated prices and cash prices, which is of particular interest given the growing importance of high-deductible health plans and a recent executive order mandating greater price transparency. Using data from five private health insurers and 142 imaging facilities in the San Francisco Bay Area, we estimate that patients could save between 10% and 22% of their insurer's in-network price by paying cash.

View Article and Find Full Text PDF